Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof-of-Concept Study
The National Institute of Allergy and Infectious Diseases (NIAD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development
P1115 is a Phase I/II, multi-center, proof-of-concept study that will explore the effects of early intensive antiretroviral therapy on achieving HIV remission in neonates. The study will also assess the safety and pharmacokinetics of early intensive antiretroviral therapy in neonates.
Years: 2016 – present
Investigator: Mutsawashe Bwakura-Dangarembizi, MBChB, MMED, MSc Cli.Epi
Locations: Harare Family Care, Seke North, and St. Mary’s CRSs